rs1013698558 - GCLC

Magnitude 4.5 · 1 study on file

Reported associations

  • Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer - Unknown journal (n.d.) · Unknown authors · PubMed 41266372

    ABSTRACT: Nineteen genomic regions have been associated with high-grade serous ovarian cancer (HGSOC). We meta-analyzed >22 million variants for 398,238 women from the Ovarian Cancer Association Consortium (OCAC), UK Biobank (UKBB) and Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) to identify novel HGSOC susceptibility loci. Eight novel variants were associated with HGSOC risk. An interesting discovery biologically was TP53 3'-UTR SNP rs78378222-T's association with HGSOC (per-T-allele relative risk (RR) = 1.44, 95% CI:1.28-1.62, P = 1.76 × 10−9). Polygenic scores (PGS) were developed using OCAC and CIMBA data and trained on FinnGen data. The optimal PGS included 64,518 variants and was associated with an odds ratio of 1.46 (95% CI:1.37-1.54) per st


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • ovarian cancer screening and surveillance options Moderate

    rs1013698558-T is associated with 2.35-fold increased risk of high-grade serous ovarian cancer through GCLC-regulated antioxidant pathways

    discuss with gynecologist about transvaginal ultrasound or CA-125 monitoring protocols